Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6845160rdf:typepubmed:Citationlld:pubmed
pubmed-article:6845160lifeskim:mentionsumls-concept:C0026995lld:lifeskim
pubmed-article:6845160lifeskim:mentionsumls-concept:C0393444lld:lifeskim
pubmed-article:6845160lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:6845160pubmed:issue5lld:pubmed
pubmed-article:6845160pubmed:dateCreated1983-6-10lld:pubmed
pubmed-article:6845160pubmed:abstractTextSevere acute meningitis developed after the use of metrizamide for lumbar myelography; cerebrospinal fluid findings included a white blood cell count of 2300, mostly polymorphonuclear cells, glucose level of 8 mg% and protein level of 253%. This apparent chemical meningitis could not be distinguished, either clinically or by cerebrospinal fluid examination, from acute bacterial meningitis. This case emphasizes that severe acute meningeal reactions, while very rare, can occur after the use of metrizamide for myelography. Such patients must be evaluated promptly to rule out bacterial meningitis and should be followed carefully for possible later sequelae.lld:pubmed
pubmed-article:6845160pubmed:languageenglld:pubmed
pubmed-article:6845160pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6845160pubmed:citationSubsetIMlld:pubmed
pubmed-article:6845160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6845160pubmed:statusMEDLINElld:pubmed
pubmed-article:6845160pubmed:monthMaylld:pubmed
pubmed-article:6845160pubmed:issn0090-3019lld:pubmed
pubmed-article:6845160pubmed:authorpubmed-author:SullivanRRlld:pubmed
pubmed-article:6845160pubmed:authorpubmed-author:WorthingtonMMlld:pubmed
pubmed-article:6845160pubmed:authorpubmed-author:FlynnRRlld:pubmed
pubmed-article:6845160pubmed:authorpubmed-author:CallanderNNlld:pubmed
pubmed-article:6845160pubmed:issnTypePrintlld:pubmed
pubmed-article:6845160pubmed:volume19lld:pubmed
pubmed-article:6845160pubmed:ownerNLMlld:pubmed
pubmed-article:6845160pubmed:authorsCompleteYlld:pubmed
pubmed-article:6845160pubmed:pagination456-8lld:pubmed
pubmed-article:6845160pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6845160pubmed:meshHeadingpubmed-meshheading:6845160-...lld:pubmed
pubmed-article:6845160pubmed:meshHeadingpubmed-meshheading:6845160-...lld:pubmed
pubmed-article:6845160pubmed:meshHeadingpubmed-meshheading:6845160-...lld:pubmed
pubmed-article:6845160pubmed:meshHeadingpubmed-meshheading:6845160-...lld:pubmed
pubmed-article:6845160pubmed:meshHeadingpubmed-meshheading:6845160-...lld:pubmed
pubmed-article:6845160pubmed:meshHeadingpubmed-meshheading:6845160-...lld:pubmed
pubmed-article:6845160pubmed:meshHeadingpubmed-meshheading:6845160-...lld:pubmed
pubmed-article:6845160pubmed:meshHeadingpubmed-meshheading:6845160-...lld:pubmed
pubmed-article:6845160pubmed:year1983lld:pubmed
pubmed-article:6845160pubmed:articleTitleAcute chemical meningitis after metrizamide-lumbar myelography.lld:pubmed
pubmed-article:6845160pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6845160pubmed:publicationTypeCase Reportslld:pubmed